The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/37767
StudyName: Eligibility Breast Cancer NCT00964704
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 22.08.2019
License: Creative Commons BY 4.0

----

Description: 
A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00964704
